An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 211810
Company: DAIICHI SANKYO INC

Medication Guide

REMS

Products on NDA 211810

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
TURALIO	PEXIDARTINIB HYDROCHLORIDE	EQ 200MG BASE	CAPSULE;ORAL	Discontinued	None	Yes	No
TURALIO	PEXIDARTINIB HYDROCHLORIDE	EQ 125MG BASE	CAPSULE;ORAL	Prescription	None	Yes	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 211810

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
08/02/2019	ORIG-1	Approval	Type 1 - New Molecular Entity	PRIORITY; Orphan	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/211810Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/211810Orig1s000TOC.cfm

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
11/16/2023	SUPPL-12	Labeling-Package Insert, Labeling-Medication Guide	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211810s012lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/211810Orig1s012ltr.pdf
04/17/2023	SUPPL-11	REMS - MODIFIED - D-N-A		Label is not available on this site.
07/14/2022	SUPPL-10	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211810s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/211810Orig1s010ltr.pdf
10/14/2022	SUPPL-9	Labeling-Container/Carton Labels, Efficacy-New Dosing Regimen, Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211810s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/211810Orig1s009ltr.pdf
10/06/2022	SUPPL-8	Efficacy-Labeling Change With Clinical Data, Labeling-Medication Guide, Labeling-Package Insert	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/211810Orig1s008ltr.pdf
10/20/2021	SUPPL-7	Labeling-Package Insert, Labeling-Medication Guide	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211810s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/211810Orig1s007ltr.pdf
12/16/2020	SUPPL-6	REMS - MODIFIED - D-N-A	Letter (PDF) Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/211810Orig1s006ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/211810Orig1s006ltr.pdf
08/04/2020	SUPPL-5	REMS - MODIFIED - D-N-A	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/211810Orig1s005ltr.pdf
04/10/2020	SUPPL-4	Labeling-Package Insert		Label is not available on this site.
04/17/2020	SUPPL-3	Labeling-Medication Guide, Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211810s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/211810Orig1s003ltr.pdf
11/19/2019	SUPPL-2	REMS - MODIFIED - D-N-A	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/211810Orig1s001,s002ltr.pdf
11/19/2019	SUPPL-1	REMS - MODIFIED - D-N-A	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/211810Orig1s001,s002ltr.pdf

Labels for NDA 211810

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
11/16/2023	SUPPL-12	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211810s012lbl.pdf
11/16/2023	SUPPL-12	Labeling-Medication Guide	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211810s012lbl.pdf
10/14/2022	SUPPL-9	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211810s009lbl.pdf
10/14/2022	SUPPL-9	Efficacy-New Dosing Regimen	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211810s009lbl.pdf
10/14/2022	SUPPL-9	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211810s009lbl.pdf
07/14/2022	SUPPL-10	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211810s010lbl.pdf
10/20/2021	SUPPL-7	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211810s007lbl.pdf
10/20/2021	SUPPL-7	Labeling-Medication Guide	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211810s007lbl.pdf
04/17/2020	SUPPL-3	Labeling-Medication Guide	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211810s003lbl.pdf
04/17/2020	SUPPL-3	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211810s003lbl.pdf
08/02/2019	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf

Top